Clinicopathologic features in HER2-positive breast cancer women in Kermanshah

Breast cancer is the most frequent malignancy among women with a peak in 40–50 years in Asia. Despite the high frequency of breast cancer among Iranian women, the epidemiological characteristics of breast cancer among Iranian patients are yet unknown. The aim of this study was to analyze clinicopathologic characteristics to identify prognostic factors for women with HER2-positive breast cancer in Kermanshah. Between 1393 and 1396, 70 patients with breast cancer, who were referred to oncologist laboratories, Kermanshah, Iran were studied. They were surveyed for age, size of the tumor, family history of the disease, laterality, type of pathology, grade, stage, tumor markers and metastasis. The mean age of patients at diagnosis was 47.11±12.39 yearsold. Size of tumor in 14 patients (20%) was 0.1-2 cm, 46 patients (66.6%) between 2.1-5 cm and 9 patients (13.4%)> 5 cm.four patients (5.7%), 37 patients (52.9%) and 27 patients (41.4%) had grade I, grade II and grade III, respectively. 30 patients (42.85%) had metastasis to other organs. 6 patients (8.57%) have a family history of any cancer. The mean age at diagnosis of breast cancer in Kermanshah is around 45 to 50 yearsold. Significant clinical features were observed in the Kermanshah patients with HER2-positive breast cancer. Furthermore, targeted anti-HER2 therapy may improve the prognosis of these patients

کلیدواژه های Clinicopathologic features in HER2-positive breast cancer women in Kermanshah:

Breast cancer ، Epidemiology ، Pathology ، HER-2 positive